UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
(AMENDMENT NO. 1)*
UNDER THE SECURITIES EXCHANGE ACT OF 1934
NPS PHARMACEUTICALS, INC.
(Name of Issuer)
COMMON STOCK, PAR VALUE $0.001 PER SHARE
(Title of Class of Securities)
62936P103
(CUSIP Number)
Patrick J. Dooley, Esq.
Akin, Gump, Strauss, Hauer & Feld, L.L.P.
590 Madison Avenue
New York, New York 10022
(212) 872-1000
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
JUNE 14, 2006
(Date of Event which Requires Filing
of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box [ ].
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule ss.240.13d-7 for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Continued on following page(s)
Page 1 of 8 Pages
Exhibit Index: Page 7
CUSIP NO. 62936P103 PAGE 2 OF 8 PAGES
031011.0004 WEST 5933271 v1
1 Names of Reporting Persons
I.R.S. Identification Nos. of above persons (entities only)
Soros Fund Management LLC
2 Check the Appropriate Box If a Member of a Group (See Instructions)
a. [ ]
b. [X]
3 SEC Use Only
4 Source of Funds (See Instructions)
AF
5 Check Box If Disclosure of Legal Proceedings Is Required Pursuant to
Items 2(d) or 2(e)
[ ]
6 Citizenship or Place of Organization
Delaware
7 Sole Voting Power
Number of 3,289,016
Shares
Beneficially 8 Shared Voting Power
Owned By 0
Each
Reporting 9 Sole Dispositive Power
Person 3,289,016
With
10 Shared Dispositive Power
0
11 Aggregate Amount Beneficially Owned by Each Reporting Person
3,289,016
12 Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions)
[ ]
13 Percent of Class Represented By Amount in Row (11)
7.14%
14 Type of Reporting Person (See Instructions)
OO, IA
CUSIP NO. 62936P103 PAGE 3 OF 8 PAGES
1 Names of Reporting Persons
I.R.S. Identification Nos. of above persons (entities only)
George Soros (in the capacity described herin)
2 Check the Appropriate Box If a Member of a Group (See Instructions)
a. [ ]
b. [X]
3 SEC Use Only
4 Source of Funds (See Instructions)
AF
6 Check Box If Disclosure of Legal Proceedings Is Required Pursuant to
Items 2(d) or 2(e)
[X]
6 Citizenship or Place of Organization
United States
7 Sole Voting Power
Number of 3,289,016
Shares
Beneficially 8 Shared Voting Power
Owned By 0
Each
Reporting 9 Sole Dispositive Power
Person 3,289,016
With
10 Shared Dispositive Power
0
11 Aggregate Amount Beneficially Owned by Each Reporting Person
3,289,016
12 Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions)
[ ]
13 Percent of Class Represented By Amount in Row (11)
7.14%
14 Type of Reporting Person (See Instructions)
IA
CUSIP NO. 62936P103 PAGE 4 OF 8 PAGES
This Amendment No. 1 to Schedule 13D relates to shares of common stock, par
value $0.001 per share (the "Shares"), of NPS Pharmaceuticals, Inc., a Delaware
corporation (the "Issuer"). This Amendment No. 1 supplementally amends the
initial statement on Schedule 13D, dated May 17, 2006 (the "Initial Statement"),
filed by the Reporting Persons (as defined herein). Capitalized terms used but
not defined herein shall have the meanings ascribed to them in the Initial
Statement. The Initial Statement is supplementally amended as follows.
ITEM 2. IDENTITY AND BACKGROUND.
This statement is filed on behalf of each of the following persons
(collectively, the "Reporting Persons"): Soros Fund Management LLC, a Delaware
limited liability company ("SFM LLC") and George Soros, a United States citizen.
The Shares which are the subject of this Statement are held for the account
of Quantum Partners LDC, a Cayman Islands exempted limited duration company
("Quantum Partners"). SFM LLC serves as principal investment manager to Quantum
Partners. As such, SFM LLC has been granted investment discretion over portfolio
investments, including the Shares, held for the account of Quantum Partners.
Mr. Soros, as Chairman of SFM LLC, has the ability to direct the investment
decisions of SFM LLC and as such may be deemed to have investment discretion
over the securities held for the account of Quantum Partners.
On December 27, 2002, Mr. Soros appealed a decision of the 11e Chambre du
Tribunal Correctionnel in Paris, France that fined him 2.2 million euros on
December 20, 2002 based on a finding of insider trading with respect to trading
in securities of Societe Generale in 1988. On March 24, 2005, the Paris Court of
Appeal affirmed the decision of the 11e Chambre du Tribunal Correctionnel and on
June 14, 2006 the Cour de Cassation upheld such decision, but ordered the Court
of Appeal to determine whether the fine should be reduced. Mr. Soros intends to
appeal this decision to the European Court of Justice.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
(a) According to information provided by the Issuer in its most recent
quarterly report on Form 10-Q, the number of Shares outstanding was 46,090,509
on May 1, 2006. Each of SFM LLC and Mr. Soros may be deemed the beneficial owner
for purposes of Section 13(d) of the Securities Exchange Act of 1934 of the
3,289,016 Shares held for the account of Quantum Partners. Such shares represent
approximately 7.14% of the issued and outstanding Shares.
(b)(i) SFM LLC may be deemed to have the sole power to direct the voting
and disposition of the 3,289,016 Shares held for the account of Quantum
Partners.
(ii) Mr. Soros, by virtue of his position with SFM LLC, may be deemed to
have the sole power to direct the voting and disposition of the 3,289,016 Shares
held for the account of Quantum Partners.
(c) The trading dates, number of shares purchased and price per share for
all transactions by the Reporting Persons since May 30, 2006 (the date of the
last filing on Schedule 13D) are set forth in Exhibit B attached hereto. All
such transactions were over-the-counter purchases for the account of Quantum
Partners.
CUSIP NO. 62936P103 PAGE 5 OF 8 PAGES
(d) The shareholders of Quantum Partners are entitled to receive, or have
the power to direct, the receipt of dividends from or the proceeds of sales of
the Shares held for the account of Quantum Partners, in accordance with their
ownership interests in Quantum Partners.
(e) Not applicable.
ITEM 7 MATERIAL TO BE FILED AS EXHIBITS.
Exhibit B - List of transactions in Issuer's common stock since May 30,
2006 (the date of the last filing on Schedule 13D).
CUSIP NO. 62936P103 PAGE 6 OF 8 PAGES
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, the
undersigned certifies that the information set forth in this statement is true,
complete and correct.
Date: June 21, 2006 SOROS FUND MANAGEMENT LLC
By: /s/ Jay Schoenfarber
--------------------------------------
Name: Jay Schoenfarber
Title: Assistant General Counsel
Date: June 21, 2006 GEORGE SOROS
By: /s/ Jay Schoenfarber
--------------------------------------
Name: Jay Schoenfarber
Title: Attorney-in-Fact
CUSIP NO. 62936P103 PAGE 7 OF 8 PAGES
EXHIBIT INDEX
PAGE NO.
B. Schedule of transactions effected since May 30, 2006 (the date of the last filing on
Schedule 13D).............................................................................. 8
CUSIP NO. 62936P103 PAGE 8 OF 8 PAGES
EXHIBIT B
RECENT TRANSACTION IN THE SECURITIES OF NPS PHARMACEUTICALS, INC.
--------------------------------------------------------------------------------------------------------------------------
DATE OF NUMBER OF AGGREGATE PRICE NATURE OF
FOR THE ACCOUNT OF TRANSACTION SECURITIES (EXCLUDING BROKERAGE COMMISSIONS) TRANSACTION
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/8/06 8,700 $5.62 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/8/06 1,300 5.63 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/8/06 10,000 5.60 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/9/06 4,724 5.6 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/9/06 2,076 5.61 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/9/06 12,600 5.6131 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/9/06 200 5.62 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/9/06 400 5.63 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/12/06 4,700 4.72 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/12/06 9,500 4.731 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/12/06 19,841 4.76 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/12/06 4,750 4.77 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/12/06 9,700 4.8 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/12/06 10,450 4.84 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/12/06 100 4.85 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/12/06 379 4.87 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/12/06 3,500 4.88 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/12/06 1,389 4.89 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/12/06 5,000 4.92 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/12/06 8,200 4.93 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/12/06 22,491 5.00 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/12/06 200 5.52 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/12/06 2,400 5.53 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/12/06 700 5.55 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/12/06 200 5.56 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/12/06 500 5.57 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/12/06 1,900 5.58 Buy
--------------------------------------------------------------------------------------------------------------------------
Quantum Partners LDC 6/12/06 4,100 5.60 Buy
--------------------------------------------------------------------------------------------------------------------------